National and Kapodistrian University of Athens
Έκφραση των πρωτεϊνών bcl-2, bax, bcl-x, fas και fas-ligand στη νόσο Hodgkin: συσχέτιση με την έκφραση της πρωτεΐνης p53, την παρουσία του ιού EBV και κλινικοεργαστηριακές παραμέτρους
Abstract
dc:descriptionIn the present study we investigated the apoptotic mechanisms of HRS neoplastic cells in Hodgkin lymphoma (HL) and the relevant clinical significance. We used a combination of in vitro techniques manipulating the apoptotic pathways of Hodgkin lymphoma cell lines, and immunohistochemistry in primary tumors. Stimulation of the extrinsic apoptotic pathway by using the FAS-agonistic antibody CH11 and HL cell lines showed that this pathway is blocked in HRS cells. The apoptotic inhibitor FLIP was involved in the blocking of the extrinsic apoptotic pathway. In contrast, in vitro activation of p53, by the MDM2 inhibitor nutlin-3, activated the intrinsic apoptotic pathway and induced significant apoptotic cell death through upregulation of the p53-targets BAX and PUMA in HL cell lines with wild-type p53. Immunohistochemistry in primary HL tumors showed that the proteins FAS, FASL, BAX and BCL-XL are expressed at high levels by HRS cells. In contrast, BCL2 was negative in almost half of the cases. p53 protein expression showed great variability. The expression levels of the above proteins were not associated with the presence of EBV virus in HRS cells. p53 protein expession levels were correlated with spontaneous apoptosis of HRS cells as evaluated by immunochemical detection of activated caspase-3 in HRS cells. In addition, high expression levels of activated caspase-3 in HRS cells were correlated with better prognosis in a cohort of previously untreated HL patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Drakos, Elias
- Δράκος, Ηλίας
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22975